Jim Kastenmayer

Jim Kastenmayer

General Counsel at ARRIVENT BIOPHARMA, INC.

Net worth: 223 574 $ as of 30/05/2026

54 year
Health Technology
Consumer Services

Profile

Dr. Jim Kastenmayer is a Secretary & General Counsel at Arrivent BioPharma, Inc. Dr. Kastenmayer was previously employed as a Secretary & General Counsel by Aeglea Biotherapeutics, Inc., a Secretary, General Counsel & Senior Vice President by Viela Bio, Inc., a Legal Director & Senior Patent Director by AstraZeneca PLC, and an IP Counsel by MedImmune LLC.
He received his undergraduate degree from the University of Virginia, a graduate degree from Georgetown University Law Center and a doctorate degree from Michigan State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/02/2026 7,386 ( 0.02% ) 223 574 $ 30/05/2026

Jim Kastenmayer active positions

CompaniesPositionStart
ARRIVENT BIOPHARMA, INC. General Counsel 31/08/2023

Former positions of Jim Kastenmayer

CompaniesPositionEnd
SPYRE THERAPEUTICS, INC. Chief Executive Officer 28/11/2022
VIELA BIO, INC. General Counsel 28/02/2021
ASTRAZENECA PLC General Counsel 30/11/2019
Corporate Officer/Principal -
See the detail of Jim Kastenmayer's experience

Training of Jim Kastenmayer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Jim Kastenmayer